Colleen Loo, MBBS, MD

Q&As

Ketamine Treatment in TRD Should Last 4 Weeks or More for Antidepressant Benefit

07/21/2023

Colleen Loo, MBBS, FRANZCP, MD, lead researcher of a groundbreaking study on the use of subcutaneous racemic ketamine for TRD, shares the rationale behind the study, its major findings, practical implications, and more.

Colleen Loo, MBBS, FRANZCP, MD,...

07/21/2023

Psych Congress Network

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

Colleen Loo, MBBS, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products